Jose Juarez
- Cancer Research top 5%
- Molecular Biology
- Oncology top 10%
- Immunology and Allergy top 5%
- Hematology top 10%
- Co-authors
- Douglas D. BoydErnst LengyelRebecca J. GumMotoharu SeikiHiroshi SatoJi Hshiung ChenDouglas BoydGarth L. Nicolson
- Topics
- Protease and Inhibitor Mechanisms (7 papers)Peptidase Inhibition and Analysis (4 papers)Cell Adhesion Molecules Research (3 papers)
- Journals
- Journal of Biological ChemistryPLoS ONEAmerican Journal of Respiratory and Critical Care Medicine
- Partner nations
- United StatesAustraliaJapan
In The Last Decade
Jose Juarez
15 papers receiving 735 citations
Peers
Comparison fields: 5 of 78
- Cancer Research 422
- Molecular Biology 377
- Oncology 246
- Immunology and Allergy 151
- Hematology 95
Countries citing papers authored by Jose Juarez
This map shows the geographic impact of Jose Juarez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jose Juarez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jose Juarez more than expected).
Fields of papers citing papers by Jose Juarez
This network shows the impact of papers produced by Jose Juarez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jose Juarez. The network helps show where Jose Juarez may publish in the future.
Co-authorship network of co-authors of Jose Juarez
This figure shows the co-authorship network connecting the top 25 collaborators of Jose Juarez. A scholar is included among the top collaborators of Jose Juarez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jose Juarez. Jose Juarez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 7 | |
| 3 | 32 | |
| 4 | 4 | |
| 5 | A monoclonal antibody targeting the human urokinase plasminogen activator receptor (uPAR) combined with bevacizumab inhibits the growth of colon cancer metastases in the liver: Differential effects mediated by tumor burden. | 2 |
| 6 | ATN-224, an orally available small molecule inhibitor of SOD1, inhibits multiple signaling pathways associated with myeloma progression and has antitumor activity in a murine model of refractory myeloma growth | 5 |
| 7 | 43 | |
| 8 | 36 | |
| 9 | 15 | |
| 10 | 19 | |
| 11 | 43 | |
| 12 | 69 | |
| 13 | 321 | |
| 14 | 36 | |
| 15 | 113 |
About Jose Juarez
Jose Juarez is a scholar working on Cancer Research, Immunology and Allergy and Oncology, having authored 15 papers that have together received 747 indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (7 papers), Peptidase Inhibition and Analysis (4 papers) and Cell Adhesion Molecules Research (3 papers). The work is most often cited by research in Cancer Research (422 citations), Immunology and Allergy (151 citations) and Oncology (246 citations). Jose Juarez has collaborated with scholars based in United States, Australia and Japan. Frequent co-authors include Douglas D. Boyd, Ernst Lengyel, Rebecca J. Gum, Motoharu Seiki, Hiroshi Sato, Ji Hshiung Chen, Douglas Boyd, Garth L. Nicolson, Hideyuki Saya and Kenneth K. Tanabe. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.